CartiHeal Performs the First 17 Cases in the Agili-C™ Implant IDE Multinational Pivotal Study

KFAR SABA, Israel, Oct. 2, 2017 /PRNewswire/ -- CartiHeal, developer of Agili-C, proprietary implants for the treatment of joint surface lesions, announced today the initiation of Its IDE clinical study. 17 patients were enrolled and operated on during the first week of the study in 3 leading European centers. Read more here

Tags:

Recent Posts